title: SpeedScreen: The "missing link" between genomics and lead discovery.
authors.affiliation: Novartis Institutes for Biomedical Research, Discovery Technologies/Basel Screening Operations, 4002 Basel, Switzerland. hartmut.zehender@pharma.novartis.com
authors.forename: Hartmut
authors.initials: H
authors.lastname: Zehender
authors.forename: Francois
authors.initials: F
authors.lastname: Le Goff
authors.forename: Natalie
authors.initials: N
authors.lastname: Lehmann
authors.forename: Ireos
authors.initials: I
authors.lastname: Filipuzzi
authors.forename: Lorenz M
authors.initials: LM
authors.lastname: Mayr
mesh_terms: D002850:Chromatography, Gel / Q000379:methods; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D015195:Drug Design; D004867:Equipment Design; D023281:Genomics; D007854:Lead / Q000032:analysis* / Q000737:chemistry; D013058:Mass Spectrometry / Q000379:methods; D008962:Models, Theoretical; D011485:Protein Binding; D012680:Sensitivity and Specificity; D021241:Spectrometry, Mass, Electrospray Ionization / Q000379:methods; D013678:Technology, Pharmaceutical / Q000295:instrumentation
chemical_list: D007854:Lead